Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Goodwill (2020 - 2025)

Northwest Biotherapeutics (NWBO) has 6 years of Goodwill data on record, last reported at $626000.0 in Q3 2025.

  • For Q3 2025, Goodwill changed 0.0% year-over-year to $626000.0; the TTM value through Sep 2025 reached $626000.0, changed 0.0%, while the annual FY2024 figure was $626000.0, 0.0% changed from the prior year.
  • Goodwill reached $626000.0 in Q3 2025 per NWBO's latest filing, roughly flat from $626000.0 in the prior quarter.
  • Across five years, Goodwill topped out at $626000.0 in Q1 2021 and bottomed at $626000.0 in Q1 2021.
  • Average Goodwill over 5 years is $626000.0, with a median of $626000.0 recorded in 2021.
  • The widest YoY moves for Goodwill: up 0.0% in 2021, down 4.28% in 2021.
  • A 5-year view of Goodwill shows it stood at $626000.0 in 2021, then changed by 0.0% to $626000.0 in 2022, then changed by 0.0% to $626000.0 in 2023, then changed by 0.0% to $626000.0 in 2024, then changed by 0.0% to $626000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Goodwill were $626000.0 in Q3 2025, $626000.0 in Q2 2025, and $626000.0 in Q1 2025.